Spheroid Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Microvesicles: Two Potential Therapeutic Strategies

Stem Cells and Development

Volumn 25, Issue 3, 2016, Pages 203-213

  Xie, Lili ^a   Mao, Mao ^b   Zhou, Liang ^a   Jiang, Bing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA;

ANTIINFLAMMATORY ACTIVITY; CELL DIFFERENTIATION; CELL SURVIVAL; CEREBROVASCULAR DISEASE; DEGENERATIVE DISEASE; IMMUNOMODULATION; ISCHEMIA; KIDNEY DISEASE; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL DERIVED MICROVESICLE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEOPLASM; OSTEOARTHROPATHY; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; SPHEROID MESENCHYMAL STEM CELL; TISSUE REPAIR; ANIMAL; CARDIOVASCULAR DISEASES; HUMAN; METABOLISM; MULTICELLULAR SPHEROID; OSTEOARTHRITIS; PROCEDURES; TRANSPLANTATION;

ANIMALS; CARDIOVASCULAR DISEASES; CELL-DERIVED MICROPARTICLES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOARTHRITIS; SPHEROIDS, CELLULAR;

EID: 84955490781     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2015.0278     Document Type: Review

References (129)

1. Russell KC, DG Phinney, MR Lacey, BL Barrilleaux, KE Meyertholen and KC O'Connor. (2010). In vitro high-capacity assay to quantify the clonal heterogeneity in trilingage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28:788-798.
2. Menssen A, T Häupl, M Sittinger, B Delorme, P Charbord and J Ringe. (2011). Differential gene expression profiling of human bone marrow-derived mesenchymal stem cells during adipogenic development. BMC Genomics 12:461.
3. Friedenstein AJ, JF Gorskaja and NN Kulagina. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267-274.
4. Huang L, C Niu and B Willard. (2015). Proteomic analysis of porcine mesenchymal stem cells derived from bone marrow and umbilical cord: implication of the proteins involved in the higher migration capability of bone marrow mesenchymal stem cells. Stem Cell Res Ther 6:77.
5. Li H, B Zhang, Y Lu, M Jorgensen, B Petersen and S Song. (2011). Adipose tissue-derived mesenchymal stem cell-based liver gene delivery. J Hepatol 54:930-938.
6. Ezquer M, F Ezquer, M Ricca, C Allers and P Conget. (2011). Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome. J Hepatol 55:1112-1120.
7. Van Linthout S, K Savvatis, K Miteva, J Peng, J Ringe, K Warstat, C Schmidt-Lucke, M Sittinger, HP Schultheiss and C Tschöpe. (2011). Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis. Eur Heart J 32:2168-2178.
8. Li Y, Y Hiroi, S Ngoy, R Okamoto, K Noma, CY Wang, HW Wang, Q Zhou, F Radtke, R Liao and JK Liao. (2011). Notch1 in bone marrow-derived cells mediates cardiac repair after myocardial infarction. Circulation 123:866-876.
9. Samper E, A Diez-Juan, JA Montero and P Sepúlveda. (2013). Cardiac cell therapy: boosting mesenchymal stem cells effects. Stem Cell Rev 9:266-280.
10. van elthoven CT, A Kavelaars, F van Bel and CJ Heijnen. (2010). Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 30:9603-9611.
11. Miranda CO, CA Teixeira, MA Liz, VF Sousa, F Franquinho, G Forte, P Di Nardo, P Pinto-Do-Ó and MM Sousa. (2011). Systemic delivery of bone marrow-derived mesenchymal stromal cells diminishes neuropathology in a mouse model for Krabbe's disease. Stem Cells 29:1738-1751.
12. Ishii M, R Shibata and Y Numaguchi. (2011). Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method. Arterioscler Thromb Vasc Biol 31:2210-2215.
13. Wang D, F Zhang, W Shen, M Chen, B Yang, Y Zhang and K Cao. (2011). Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. Int J Cardiol 152:314-320.
14. Guiducci S, M Manetti, E Romano, B Mazzanti, C Ceccarelli, S Dal Pozzo, AF Milia, S Bellando-Randone, G Fiori, et al. (2011). Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Ann Rheum Dis 70:2011-2021.
15. Tsai KS, SH Yang, YP Lei, CC Tsai, HW Chen, CY Hsu, LL Chen, HW Wang, SA Miller, et al. (2011). Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology 141:1046-1056.
16. Funes JM, S Henderson, R Kaufman, JM Flanagan, M Robson, B Pedley, S Moncada and C Boshoff. (2014). Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival. Mol Cancer 13:20.
17. Ananthanarayanan A, B Nugraha, M Triyatni, S Hart, S Sankuratri and H Yu. (2014). Scalable spheroid model of human hepatocytes for hepatitis C infection and replication. Mol Pharm 11:2106-2114.
18. Huang YJ and SH Hsu. (2014). Acquisition of epithelial-mesenchymal transition and cancer stem-like phenotypes within chitosan-hyaluronan membrane-derived 3D tumor spheroids. Biomaterials 35:10070-10079.
19. Huang AH, MJ Farrell, M Kim and RL Mauck. (2010). Long-term dynamic loading improves the mechanical properties of chondrogenic mesenchymal stem cell-laden hydrogel. Eur Cell Mater 19:72-85.
20. Coutu DL, J Cuerquis, R El Ayoubi, KA Forner, R Roy, M François, M Griffith, D Lillicrap, AM Yousefi, MD Blostein and J Galipeau. (2011). Hierarchical scaffold design for mesenchymal stem cell-based gene therapy of hemophilia B. Biomaterials 32:295-305.
21. Lee RH, AA Pulin, MJ Seo, DJ Kota, J Ylostalo, BL Larson, L Semprun-Prieto, P Delafontaine and DJ Prockop. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63.
22. Bartosh TJ, JH Ylöstalo, A Mohammadipoor, N Bazhanov, K Coble, K Claypool, RH Lee, H Choi and DJ Prockop. (2010). Aggregation of human mensenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A 107:13724-13729.
23. Hoyer M, C Meier, A Breier, J Hahner, G Heinrich, N Drechsel, M Meyer, C Rentsch, LA Garbe, et al. (2015). In vitro characterization of self-assembled anterior cruciate ligament cell spheroids for ligament tissue engineering. Histochem Cell Biol 143:289-300.
24. Huang GS, CS Tseng, B Linju Yen, LG Dai, PS Hsieh and SH Hsu. (2013). Solid freeform-fabricated scaffolds designed to carry multicellular mesenchymal stem cell spheroids for cartilage regeneration. Eur Cell Mater 26:179-194.
25. Futrega K, JS Palmer, M Kinney, WB Lott, MD Ungrin, PW Zandstra and MR Doran. (2015). The microwell-mesh: a novel device and protocol for the high throughput manufacturing of cartilage microtissues. Biomaterials 62:1-12.
26. Wise JK, AI Alford, SA Goldstein and JP Stegemann. (2014). Comparison of uncultured marrow mononuclear cells and culture-expanded mesenchymal stem cells in 3D collagen-chitosan microbeads for orthopedic tissue engineering. Tissue Eng Part A 20:210-224.
27. Tseng TC and SH Hsu. (2014). Substrate-mediated nanoparticle/gene delivery to MSC spheroids and their applications in peripheral nerve regeneration. Biomaterials 35:2630-2641.
28. Pant S, H Hilton and ME Burczynski. (2012). The multifaceted exosome: biogenesis role in normal and aberrant cellular function, and frontiers for pharmacological and biomaker opportunities. Biochem Pharmacol 83:1484-1494.
29. Cocucci E and J Meldolesi. (2015). Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol 25:364-372.
30. Akao Y, A Iio, T Itoh, S Noguchi, Y Itoh, Y Ohtsuki and T Naoe. (2011). Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol Ther 19:395-399.
31. Cocucci E, G Racchetti and J Meldolesi. (2009). Shedding microvesicles: artefacts no more. Trends Cell Biol 19:43-51.
32. Jeong JO, JW Han, JM Kim, HJ Cho, C Park, N Lee, DW Kim and YS Yoon. (2011). Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cell in experimental myocardial infarction and diabetic neuropathy. Cir Res 108 1340-1347.
33. Soehnlein O and L Lindbom. (2010). Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10:427-439.
34. Yeh HY, BH Liu, M Sieber and SH Hsu. (2014). Substrate-dependent gene regulation of self-assembled human MSC spheroids on chitosan membranes. BMC Genomics 15:10.
35. Ylöstalo JH, TJ Bartosh, K Coble and DJ Prockop. (2012). Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an antiinflammatory phenotype. Stem Cells 30:2283-2296.
36. Bartosh TJ, JH Ylöstalo, N Bazhanov, J Kuhlman and DJ Prockop. (2013). Dynamic compaction of human mesenchymal stem/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulator of inflammation and immunity (PEG2, TSG6, and STC1). Stem Cells 31:2443-2456.
37. Wang W, K Itaka, S Ohba, N Nishiyama, UI Chung, Y Yamasaki and K Kataoka. (2009). 3D spheroids culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. Biomaterials 30:2705-2715.
38. Hsu SH, GS Huang, SY Lin, F Feng, TT Ho and YC Liao. (2012). Enhanced chondrogenic differentiation potential of human gingival fibroblasts by spheroid formation on chitosan membranes. Tissue Eng Part A 18:67-79.
39. Yeh HY, BH Liu and SH Hsu. (2012). The calcium-dependent regulation of spheroid formation and cardiomyogenic differentiation for MSCs on chitosan membranes. Biomaterials 33:8943-8954.
40. Yoon HH, SH Bhang, JY Shin, J Shin and BS Kim. (2012). Enhanced cartilage formation via three-dimensional cell engineering of human adipose-derived stem cells. Tissue Eng Part A 18:1949-1956.
41. Assmus B, J Honold, V Schächinger, MB Britten, U Fischer-Rasokat, R Lehmann, C Teupe, K Pistorius, H Martin, et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 335:1222-1232.
42. Zhu W, J Chen, X Cong and X Chen. (2006). Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cell. Stem Cells 24:416-425.
43. Bhang SH, SW Cho, WG La, TJ Lee, HS Yang, AY Sun, SH Baek, JW Rhie and BS Kim. (2011). Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Biomaterials 32:2734-2747.
44. Zhang Q, AL Nguyen, S Shi, C Hill, P Wilder-Smith, TB Krasieva and AD Le. (2012). Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis. Stem Cells Dev 21:937-947.
45. Bhang SH, S Lee, JY Shin, TJ Lee and BS Kim. (2012). Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization. Tissue Eng Part A 18:2138-2147.
46. Murphy KC, SY Fang and JK Leach. (2014). Human mesenchymal stem cell spheroids in fibrin hydrogels exhibit improved cell survival and potential for bone healing. Cell Tissue Res 357:91-99.
47. Hsu SH, GS Huang and F Feng. (2012). Isolation of the multipotent MSC subpopulation from human gingival fibroblasts by culturing on chitosan membranes. Biomaterials 33:2642-2655.
48. Huang GS, LG Dai, BL Yen and SH Hsu. (2011). Spheroid formation of mesenchymal stem cells on chitosan and chitosan-hyaluronan membranes. Biomaterials 32:6929-6945.
49. Laschke MW, TE Schank, C Scheuer, S Kleer, S Schuler, W Metzger, D Eglin, M Alini and MD Menger. (2013). Three-dimensional spheroids of adipose-derived mesenchymal stem cells are potent initiators of blood vessel formation in porous polyurethane scaffolds. Acta Biomater 9:6876-6884.
50. Derda R, A Laromaine, A Mammoto, SK Tang, T Mammoto, DE Ingber and GM Whitesides. (2009). Papaer-supported 3D cell culture for tissue-based bioassays. Proc Natl Acad Sci U S A 106:18457-18462.
51. Ota H and N Miki. (2013). Microtechnology-based three-dimensional spheroid formation. Front Biosci (Elite Ed) 5:37-48.
52. Burdick JA and G Vunjak-Novakovic. (2009). Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A 15:205-219.
53. Uzer G, WR Thompson, B Sen, Z Xie, SS Yen, S Miller, G Bas, M Styner, CT Rubin, et al. (2015). Cell mechanosensitivity to extremely low-magnitude signals is enabled by a LINCed nucleus. Stem Cells 33:2063-2076.
54. Watt FM and BL Hogan. (2000). Out of Eden: stem cells and their niches. Science 287:1427-1430.
55. Pelttari K, A Winter, E Steck, K Goetzke, T Hennig, BG Ochs, T Aigner and W Richter. (2006). Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 54:3254-3266.
56. Arufe MC, A De la Fuente, I Fuentes-Boquete, FJ De Toro and FJ Blanco. (2009). Differentiation of synovial CD-105(+) human mesenchymal stem cells into chondrocyte-like cells through spheroid formation. J Cell Biochem 108:145-155.
57. Arufe MC, A De la Fuente, J Mateos, I Fuentes, FJ De Toro and FJ Blanco. (2011). Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma. Stem Cells Dev 20:1199-1212.
58. Giovannini S, J Diaz-Romero, T Aigner, P Heini, P Mainil-Varlet and D Nesic. (2010). Micromass coculture of human articular chondrocytes and human bone marrow mesenchymal stem cells to investigate stable neocartilage tissue formation in vitro. Eur Cells Mater 20:245-259.
59. Farrell MJ, MB Fisher, AH Huang, JI Shin, KM Farrell and RL Mauck. (2014). Functional properties of bone marrow-derived MSC-based engineered cartilage are unstable with very long-term in vitro culture. J Biomech 47:2173-2182.
60. Farrel MJ, JI Shin, LJ Smith and RL Mauck. (2015). Functional consequences of glucose and oxygen deprivation on engineered mesenchymal stem cell-based cartilage constructs. Osteoarthritis Cartilage 23:134-142.
61. Arufe MC, A De la Fuente, I Fuentes, FJ de Toro and FJ Blanco. (2010). Chondrogenic potential of subpopulations of cells expressing mesenchymal stem cell markers derived from human synovial membranes. J Cell Biomech 111:834-845.
62. Hill E, T Boontheekul and DJ Mooney. (2006). Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci U S A 103:2494-2499.
63. Ceccaldi C, R Bushkalova, C Alfarano, O Lairez, D Calise, P Bourin, C Frugier, C Rouzaud-Laborde, D Cussac, et al. (2014). Evaluation of polyelectrolyte complex-based scaffolds for mesenchymal stem cell therapy in cardiac ischemia treatment. Acta Biomater 10:901-911.
64. Ge J, L Guo, S Wang, Y Zhang, T Cai, RC Zhao and Y Wu. (2014). The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev 10:295-303.
65. Guo L, J Ge, Y Zhou, S Wang, RC Zhao and Y Wu. (2014). Three-dimensional spheroid-cultured mesenchymal stem cells devoid of embolism attenuate brain stroke injury after intra-arterial injection. Stem Cells Dev 23:978-989.
66. Skiles ML, B Hanna, L Rucker, A Tipton, A Brougham-Cook and JO Blanchette. (2015). ASC spheroid geometry and culture oxygenation differentially impact induction of pre-angiogenic behaviors in endothelial cells. Cell Transplant 24:2323-2335.
67. Schifferli JA. (2011). Microvesicles are messengers. Semin Immunopathol 33:393-394.
68. György B, ME Hung, XO Breakefield and JN Leonard. (2015). Therapeutic application of extracellular vesicles: clinical promise and open questions. Annu Rev Pharmacol Toxicol 55:439-464.
69. Théry C, M Ostrowski and E Segura. (2009). Membrane vesicles as conveyors of immune responses. Nav Rev Immunol 9:581-593.
70. Biancone L, S Bruno, MC Dereqibu, C Tetta and G Camussi. (2012). Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 27:3037-3042.
71. Sabin K and N Kikyo. (2014). Microvesicles as mediators of tissue regeneration. Transl Res 163:286-295.
72. Maumus M, C Jorgensen and D Noël. (2013). Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. Biochimie 95:2229-2234.
73. Quesenberry PJ, LR Goldberg, JM Aliotta, MS Dooner, MG Pereira, S Wen and G Camussi. (2014). Cellular phenotype and extracellular vesicles: basic and clinical considerations. Stem Cells Dev 23:1429-1436.
74. Huang YC, O Parolini and L Deng. (2013). The potential role of microvesicles in mesenchymal stem cell-based therapy. Stem Cells Dev 22:841-844.
75. Katsuda T, R Tsuchiya, N Kosaka, Y Yoshioka, K Takagaki, K Oki, F Takeshita, Y Sakai, M Kuroda and T Ochiya. (2013). Human adipose-tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep 3:1197.
76. Ratajczak J, M Wysoczynski, F Hayek, A Janowska-Wieczorek and MZ Ratajczak. (2006). Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20:1487-1495.
77. Camussi G, MC Deregibus, S Bruno, V Cantaluppi and L Biancone. (2010). Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78:838-848.
78. Kim HS, DY Choi, SJ Yun, SM Choi, JW Kang, JW Jung, D Hwang, KP Kim and DW Kim. (2012). Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res 11:839-849.
79. Choi DS, DK Kim, YK Kim and YS Gho. (2013). Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics 13:1554-1571.
80. Sze SK, DP de Kleijn, RC Lai, E Khia Way Tan, H Zhao, KS Yeo, TY Low, Q Lian, CN Lee, et al. (2007). Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics 6:1680-1689.
81. Lai RC, SS Tan, BJ Teh, SK Sze, F Arslan, DP de Kleijn, A Choo and SK Lim. (2012). Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics 2012: 971907.
82. Bruno S, C Grange, MC Deregibus, RA Calogero, S Saviozzi, F Collino, L Morando, A Busca, M Falda, et al. (2009). Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053-1067.
83. Zhu YG, XM Feng, J Abbott, XH Fang, Q Hao, A Monsel, JM Qu, MA Matthay and JW Lee. (2014). Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 32:116-125.
84. Ratajczak J, K Miekus, M Kucia, J Zhang, R Reca, P Dvorak and MZ Ratajczak. (2006). Embryonic stem cells-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20:847-856.
85. Deregibus MC, V Cantaluppi, R Calogero, M Lo Iacono, C Tetta, L Biancone, S Bruno, B Bussolati and G Camussi. (2007). Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110:2440-2448.
86. Valadi H, K Ekström, A Bossios, M Sjöstrand, JJ Lee and JO Lötvall. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659.
87. Chen TS, RC Lai, MM Lee, AB Choo, CN Lee and SK Lim. (2010). Mesenchymal stem cell seceretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 38:215-224.
88. Chen TS and Lim SK. (2013). Measurement of precursor miRNA in exosomes from human ESC-dervied mesenchymal stem cells. Methods Mol Biol 1024:69-86.
89. Koh W, CT Sheng, B Tan, QY Lee, V Kuznetsov, LS Kiang and V Tanavde. (2010). Analysis of deep sequencing microRNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of hepatic nuclear factor 4 alpha. BMC Genomics 11 (Suppl. 1):S6.
90. Feng Y, W Huang, M Wani, X Yu and M Ashraf. (2014). Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One 9:e88685.
91. Xin H, Y Li, Z Liu, X Wang, X Shang, Y Cui, ZG Zhang and M Chopp. (2013). MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells 31:2737-2746.
92. Xin H, Y Li, B Buller, M Katakowski, Y Zhang, X Wang, X Shang, ZG Zhang and M Chopp. (2012). Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30:1556-1564.
93. Lee JK, SR Park, BK Jung, YK Jeon, YS Lee, MK Kim, YG Kim, JY Jang and CW Kim. (2013). Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One 8:e84256.
94. Katakowski M, B Buller, X Zheng, Y Lu, T Rogers, O Osobamiro, W Shu, F Jiang and M Chopp. (2013). Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett 335:201-204.
95. Joyce N, G Annett, L Wirthlin, S Olson, G Bauer and JA Nolta. (2010). Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 5:933-946.
96. Ludwig AK and B Giebel. (2012). Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol 44:11-15.
97. Lee Y, S EI Andaloussi and MJ Wood. (2012). Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 21(R1):R125-R134.
98. Schorey JS and S Bhatnagar. (2008). Exosome function: from tumor immunology to pathogen biology. Traffic 9:871-881.
99. Candelario KM and DA Steindler. (2014). The role of extracellular vesicles in the progression of neurodegenerative disease and cancer. Trends Mol Med 20:368-374.
100. Lee TH, E D'Asti, N Magnus, K Al-Nedawi, B Meehan and J Rak. (2011). Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'. Semin Immunopathol 33:455-467.
101. Bruno S, F Collino, MC Deregibus, C Grange, C Tetta and G Camussi. (2013). Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev 22:758-771.
102. Mizrak A, MF Bolukbasi, GB Ozdener, GJ Brenner, S Madlener, EP Erkan, T Ströbel, XO Breakefield and O Saydam. (2013). Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol Ther 21:101-108.
103. Burns JS, A Safwat, G Grisendi, M Kassem and M Dominici. (2012). Sarcomas as a mise en abyme of mesenchymal stem cells: exploiting interrelationships for cell mediated anticancer therapy. Cancer Lett 325:1-10.
104. Ono M, N Kosaka, N Tominaga, Y Yoshioka, F Takeshita, RU Takahashi, M Yoshida, H Tsuda, K Tamura and T Ochiya. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal 7:ra63.
105. Pascucci L, V Coccè, A Bonomi, D Ami, P Ceccarelli, E Ciusani, L Viganò, A Locatelli F Sisto, et al. (2014). Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release 192:262-270.
106. Roccaro AM, A Sacco, P Maiso, AK Azab, YT Tai, M Reagan, F Azab, LM Flores, F Campigotto, et al. (2013). BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest 123:1542-1555.
107. Wang M, C Zhao, H Shi, B Zhang, L Zhang, X Zhang, S Wang, X Wu, T Yang, et al (2014). Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br J Cancer 110:1199-1210.
108. Li Y, J Chen, L Wang, M Lu and M Chopp. (2001). Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56:1666-1672.
109. Tsai LK, Z Wang, J Munasinghe, Y Leng, P Leeds and DM Chuang. (2011). Mesenchymal stem cells primed with valproate and lithium robustly migrate to infracted regions and facilitate recovery in a stroke model. Stroke 42:2932-2939.
110. Mokarizadeh A, N Delirezh, A Morshedi, G Mosayebi, AA Farshid and K Mardani. (2012). Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunol Lett 147:47-54.
111. Xin H, Y Li, Y Cui, JJ Yang, ZG Zhang and M Chopp. (2013). Systemic administration of exosomes releasesd from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 33:1711-1715.
112. Yang Y, A Otte and R Hass. (2015). Human mesenchymal stroma/stem cells exchange membrane proteins and alter functionality during interaction with different tumor cell lines. Stem Cells Dev 24:1205-1222.
113. Amdur RL, LS Chawla, S Amodeo, PL Kimmel and CE Palant. (2009). Outcomes following diagnosis of acute renal failure in U.S. veterans: focus on acute tubular necrosis. Kidney Int 76:1089-1097.
114. Eirin A, XY Zhu, JD Krier, H Tang, KL Jordan, JP Grande, A Lerman, SC Textor and LO Lerman. (2012). Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 30:1030-1041.
115. Zhu XY, V Urbieta-Caceres, JD Krier, SC Textor, A Lerman and LO Lerman. (2013). Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms. Stem Cells 31:117-125.
116. Tögel F, K Weiss, Y Yang, Z Hu, P Zhang and C Westenfelder. (2007). Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292:1626-1635.
117. Bi B, R Schmitt, M Israilova, H Nishio and LG Cantley. (2007). Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18:2486-2496.
118. Gatti S, S Bruno, MC Deregibus, A Sordi, V Cantaluppi, C Tetta and G Camussi. (2011). Microvesicle derived from human adult mesenchymal stem cells protect against ischemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 26:1474-1483.
119. Lindoso RS, F Collino, S Bruno, DS Araujo, JF Sant'Anna, C Tetta, P Provero, PJ Quesenberry, A Vieyra, M Einicker-Lamas and G Camussi. (2014). Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury. Stem Cells Dev 23:1809-1819.
120. Tomasoni S, L Longaretti, C Rota, M Morigi, S Conti, E Gotti, C Capelli, M Introna, G Remuzzi and A Benigni. (2013). Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 22:772-780.
121. Kunter U, S Rong, P Boor, F Eitner, G Müller-Newen, Z Djuric, CR van Roeyen, A Konieczny, T Ostendorf, et al. (2007). Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 18:1754-1764.
122. Karp JM and GS Leng Teo. (2009). Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4:206-216.
123. Duttenhoefer F, R Lara de Freitas, T Meury, M Loibl, LM Benneker, RG Richards, M Alini and S Verrier. (2013). 3D scaffolds co-seeded with human endothelial progenitor and mesenchymal stem cells: evidence of prevascularisation within 7 days. Eur Cell Mater 26:49-64.
124. Zhang Y, M Chopp, Y Meng, M Katakowski, H Xin, A Mahmood and Y Xiong. (2015). Effect of exosomes derived from multipotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brains injury. J Neurosurg 122:856-867.
125. Zhuang X, X Xiang, W Grizzle, D Sun, S Zhang, RC Axtell, S Ju, J Mu, L Zhang, et al. (2011). Treatment of brain inflammatory disease by delivery exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19:1769-1779.
126. Chevillet JR, Q Kang, IK Ruf, HA Briggs, LN Vojtech, SM Hughes, HH Cheng, JD Arroyo, EK Meredith, et al. (2014). Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci U S A 111:14888-14893.
127. de Jong R, GP van Hout, JH Houtgraaf, K Kazemi, C Wallrapp, A Lewis, G Pasterkamp, IE Hoefer and HJ Duckers. (2014). Intracoronary infusion of encapsulated glucagon-like peptidlle-1-eluting mesenchyma stem cells preserves left ventricular function in a porcine model of acute myocardial infarction. Circ Cardiovasc Interv 7:673-683.
128. Yang JX, N Zhang, HW Wang, P Gao, QP Yang and QP Wen. (2015). CXCR4 overexpression in mesenchymal stem cells facilitates treatment of acute lung injury in rats. J Biol Chem 290:1994-2006.
129. Maguire CA, L Balaj, S Sivaraman, MH Crommentuijn, M Ericsson, L Mincheva-Nilsson, V Baranov, D Gianni, BA Tannous, et al. (2012). Microvesicle-associated AAV vector as a novel gene delivery system. Mol Ther 20:960-971.